---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-211446"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T13:08:55.638474+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD Q2 net loss narrows to $2.4M as royalty transition continues

## Summary
- Net loss from continuing ops of $2.4M ($0.24 per share) vs $14.9M ($1.70) in Q2 2022.
- License and service revenue rose to $0.4M from $0.3M year-over-year, driven by Mayne License Agreement.
- Total operating expenses fell 80.4% to $2.9M reflecting wind-down of manufacturing and commercial ops.
- CEO says company is focused on cost reduction and cash conservation during ongoing business transformation.

## SEC filing metadata
- accession: 0001193125-23-211446
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312523211446/0001193125-23-211446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312523211446/d513429d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-211446
- JSON: https://secwatch.observer/filing/0001193125-23-211446.json
- Plain text: https://secwatch.observer/filing/0001193125-23-211446.txt

## Key facts
- Earnings Releases
  TherapeuticsMD, Inc. reported second quarter ended June 30, 2023 results: revenue $0.4 million, net income $2.4 million, EPS $(0.24) per basic and diluted common share.
  - Period: second quarter ended June 30, 2023
  - Revenue: $0.4 million
  - Net income: $2.4 million
  - EPS: $(0.24) per basic and diluted common share
  - Result: reported results
  source text: License and service revenues from continuing operations, which are revenues related to license agreements, were $0.4 million for the quarter ended June 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000119312523211446/0001193125-23-211446-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.